1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6896B091768BABC796525829700396C9F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/how-medical-affairs-creates-value-relationships-service-critical-external-groups?opendocument
18
19opendocument
203.239.87.20
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Affairs Excellence

How Medical Affairs Creates Value & Relationships through Service to Critical External Groups

ID: POP-293


Features:

15 Info Graphics

69 Data Graphics

1250+ Metrics


Pages: 101


Published: Pre-2019


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
With unprecedented changes in the healthcare industry, the Medical Affairs function is now responsible for building relationships and demonstrating value across a wide range of stakeholders. While Medical Affairs has traditionally served established stakeholder groups (such as payers, advocacy, guidelines organizations, government agencies and ACOs/IDNs/HCPs), it is now also grappling with serving emerging groups such as specialty pharmacies, group purchasing organizations, large employer groups and pathway vendors.

This makes it vital for
Medical Affairs to adapt critical new tools, services and activities to serve the needs of these diverse stakeholder groups.

Best Practices, LLC conducted this benchmarking research to examine the activities, services, roles and tools used by Medical Affairs functions from leading pharma, biotech and medical device companies to develop relationships with both established and emerging stakeholder groups. This report also highlights the key performance indicators and best practices used to demonstrate value to stakeholders, both internal and external.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Communications; Manufacturing; Consumer Products; Medical Device; Chemical; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbott; Amgen; ApotheCom; Astellas; Bayer; Boehringer Ingelheim; cipla; CSL Behring; EMD Serono; Ferring Pharmaceuticals; Genentech; Janssen; Jazz Pharmaceuticals; Novartis; Novo Nordisk; Otonomy; Pfizer; Roche; Roche Diagnostics; Sandoz; Sanofi; Sanofi Genzyme; Santen; Seattle Genetics; Shire; Siemens Healthcare; Sunovion; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; Tillotts Pharma; UCB Pharma; Upsher-Smith; Vifor Pharma

Study Snapshot

Best Practices, LLC engaged 50 Medical Affairs leaders from 33 pharmaceutical and diagnostic companies through a benchmarking survey instrument.

Key topics covered in this report include:

  • Medical Affairs Interactions with External Groups
  • Specialized Tools, Roles, Services and Involvement Timeline
  • Changing Policies, Activities and KPIs of Medical Affairs to Work with External Groups
  • Global Standards, Best Practices and Challenges


Key Findings

Sample key insights uncovered from this report are noted below. Detailed findings are available in the full report.
  • Medical Affairs Work with Payer Groups
    • Medical Affairs Groups to Involve: Health Outcome Researchers, Medical Field Teams and Medical Information Groups are involved most frequently with Payers.
  • Medical Affairs Work with Advocacy Groups
    • Medical Affairs Services: Scientific exchanges with decision-makers and influencers are delivered at 53% of the companies. Collecting and integrating value pathway, medical insights on unmet needs and scientific, clinical and HEOR data presentations are delivered to advocacy groups by 52% and 48% of companies.
  • Medical Affairs Work with ACOs/IDNs/HCPs
    • KPIs: Coverage determination is the most used KPI to measure the success of Medical Affairs' work.
  • Medical Affairs Work with Specialty Pharmacies
    • Specialized Tools: Clinical trial recruitment or support, disease state education tools and online scientific publications are the most impactful specialized tools.
Table of Contents

I.Executive Summary
Study Structure & Design
Participated Benchmark Class
Key Findings and Recommendations
II.Interactions with External Groups
External Groups: Types Engaged by Medical Affairs
External Groups: Importance and Work Effectiveness
III.Tools, Roles, Services, KPIs and Interactions Timeline: Established Groups
Payers
Advocacy Groups
Guidelines Organizations
Government Agencies
ACOs/IDNs/HCPs
IV.Tools, Roles, Services, KPIs and Interactions Timeline: Emerging Groups
Specialty Pharmacies
Group Purchasing Organizations
Large Employer Groups
Pathway Vendors
V.Regulation, Medical Affairs’ Global Work and Challenges
Medical Affairs Work at Federal and State Levels
Tactics to Adjust Medical Affairs Work Globally
Challenges of Working with External Groups
VI.Participants’ Demographics
Geographic Responsibility of Medical Affairs
Industries Supported by Medical Affairs

    List of Charts & Exhibits

    I. Medical Affairs Interactions
    • Association of Medical Affairs with established and emerging external groups
    • Importance of external groups to the work conducted within Medical Affairs
    • Effectiveness of work conducted by Medical Affairs with external groups
    • Importance vs effectiveness matrix: TBC, U.S. only and global segment
    • Top Medical Affairs functions involved with external groups

    II. Medical Affairs Work with Payer Groups
    • Payer groups dashboard: Key tools, roles, Medical Affairs groups involved with payer work and relationship timeline
    • Functional involvement with payers
    • Tools deployed to showcase value
    • Services offered by Medical Affairs to payers
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups - U.S. only and global segment
    • Key performance indicators for work with payers
    • Medical Affairs activities conducted with payers

    III. Medical Affairs Work with Advocacy Groups
    • Advocacy groups dashboard: Key tools, roles, Medical Affairs groups that drive advocacy relationship and relationship timeline
    • Functional involvement with advocacy groups
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to advocacy groups
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups - U.S. only and global segment
    • Key performance indicators for work with advocacy groups
    • Medical Affairs activities with advocacy groups

    IV. Medical Affairs Work with Guidelines Organizations
    • Guidelines organizations dashboard: Key tools, roles, Medical Affairs groups that drive guidelines organizations relationship and relationship timeline
    • Functional involvement with guidelines organizations
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to guidelines organizations
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups
    • Medical Affairs activities conducted with guidelines organizations

    V. Medical Affairs Work with Government Agencies
    • Government agencies dashboard: Key tools, roles, Medical Affairs groups that drive relationships with government agencies and relationship timeline
    • Functional involvement of Medical Affairs with government agencies
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to government agencies
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups
    • Key performance indicators for work with government agencies
    • Medical Affairs activities conducted with government agencies

    VI. Medical Affairs Work with ACOs/IDNs/HCPs
    • ACO/IDN/HCP dashboard: Key tools, roles, Medical Affairs groups that drive ACO/IDN/HCP relationship and relationship timeline
    • Functional involvement of Medical Affairs with ACOs/IDNs/HCPs
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to ACOs/IDNs/HCPs
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups - U.S. only and global segment
    • Key performance indicators for work with ACOs/IDNs/HCPs
    • Medical Affairs activities conducted with ACOs/IDNs/HCPs

    VII. Medical Affairs Work with Specialty Pharmacies
    • Specialty pharmacies dashboard: Key tools, roles, Medical Affairs groups that drive relationships with specialty pharmacies and relationship timeline
    • Functional involvement of Medical Affairs with specialty pharmacies
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to specialty pharmacies
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups

    VIII. Medical Affairs Work with Summary Findings for Group Purchasing Organizations
    • Group purchasing organizations (GPOs) dashboard: Key tools, roles, Medical Affairs groups that drive relationships with GPOs and relationship timeline
    • Functional involvement of Medical Affairs with group purchasing organizations
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to GPOs
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups

    IX. Medical Affairs Work with Large Employer Groups
    • Large employer groups dashboard: Key tools, roles, Medical Affairs groups that drive relationships with large employer groups and relationship timeline
    • Functional involvement of Medical Affairs with large employer groups
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to large employer groups
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups

    X. Medical Affairs Work with Pathway Vendors
    • Pathway vendors dashboard: Key tools, roles, Medical Affairs groups that drive relationships with pathway vendors and relationship timeline
    • Functional involvement of Medical Affairs with pathway vendors
    • Tools deployed by Medical Affairs to showcase value
    • Services provided by Medical Affairs to showcase value to pathway vendors
    • Effectiveness of the listed specialized tools used by Medical Affairs with various groups

    XI. Work at Federal and State Levels; Challenges Faced
    • Evolving Medical Affairs policies and procedures
    • Activities supported by Medical Affairs at federal and state levels
    • Approaches used to establish global Medical Affairs standards of excellence
    • Challenges faced by Medical Affairs in working with external groups